NeoTX Therapeutics Funding: $60M Raised, Series C (2020)
NeoTX Therapeutics is based in Rehovot, Israel. It has raised $60M in total funding. Latest round: Series C. Backed by Tako Ventures.
NeoTX Therapeutics funding overview
NeoTX Therapeutics is based in Rehovot, Israel. NeoTX Therapeutics has raised $60M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series C announced in February 2020. The round record for NeoTX Therapeutics runs through 2020; nothing later has been disclosed. Investors on record include Tako Ventures.
NeoTX Therapeutics at a glance
Total raised
$60M
Latest round
Series C
Latest round date
February 2020
Headquarters
Rehovot, Israel
Notable investors
Tako Ventures
Frequently asked about NeoTX Therapeutics funding
How much has NeoTX Therapeutics raised?
NeoTX Therapeutics has raised $60M in total disclosed funding across the rounds on record.
Who has invested in NeoTX Therapeutics?
Tako Ventures are named among the investors backing NeoTX Therapeutics.
What was the latest NeoTX Therapeutics funding round?
The most recent disclosed round is a Series C, announced in February 2020.
Where is NeoTX Therapeutics based?
NeoTX Therapeutics is based in Rehovot, Israel.
When did NeoTX Therapeutics last raise?
The last disclosed NeoTX Therapeutics round closed in February 2020 at Series C.
Totals shown for NeoTX Therapeutics aggregate every disclosed round on file. To see how that compares, browse the companies in Rehovot and the investors behind them below.
